Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Mirabegron Sustained-release Tablets
- Product Name
- 米拉贝隆缓释片
- Approval Number
- 国药准字H20253036
- Approval Date
- Jan 2, 2025
NMPA
Mirabegron Sustained-release Tablets
- Product Name
- 米拉贝隆缓释片
- Approval Number
- 国药准字H20253035
- Approval Date
- Jan 2, 2025
NMPA
Tofacitinib CitrateTablets
- Product Name
- 枸橼酸托法替布片
- Approval Number
- 国药准字H20243600
- Approval Date
- Apr 24, 2024
NMPA
Olmesartan Medoxomil Tablets
- Product Name
- 奥美沙坦酯片
- Approval Number
- 国药准字H20233832
- Approval Date
- Jan 19, 2024
NMPA
Clinical Trials
No trials found
News
No news found